GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OCSE:BAVA) » Definitions » Marketable Securities

Bavarian Nordic AS (OCSE:BAVA) Marketable Securities : kr875 Mil (As of Sep. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Bavarian Nordic AS Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Bavarian Nordic AS's Marketable Securities for the quarter that ended in Sep. 2024 was kr875 Mil.

Bavarian Nordic AS's annual Marketable Securities declined from Dec. 2021 (kr3,125 Mil) to Dec. 2022 (kr2,270 Mil) and declined from Dec. 2022 (kr2,270 Mil) to Dec. 2023 (kr390 Mil).

Bavarian Nordic AS Marketable Securities Historical Data

The historical data trend for Bavarian Nordic AS's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bavarian Nordic AS Marketable Securities Chart

Bavarian Nordic AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 174.82 1,384.12 3,124.80 2,269.76 390.25

Bavarian Nordic AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 474.06 390.25 1,431.09 1,420.78 874.80

Bavarian Nordic AS Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Bavarian Nordic AS  (OCSE:BAVA) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Bavarian Nordic AS Marketable Securities Related Terms

Thank you for viewing the detailed overview of Bavarian Nordic AS's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bavarian Nordic AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bavarian Nordic AS (OCSE:BAVA) » Definitions » Marketable Securities
Comparable Companies
OCSE:GUBRA OCSE:PEG OCSE:ALK B OCSE:ZEAL VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE UTHR MRNA NEUP SMMT OCSE:GMAB INCY
Traded in Other Exchanges
BVNRY:USA BVNKF:USA BAVAc:UK 0DPB:UK BV3:Germany BAVA:Austria
Address
Philip Heymans Alle 3, Hellerup, DNK, DK-2900
Website
https://www.bavarian-nordic.com
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora and Vivotif.

Bavarian Nordic AS Headlines

No Headlines